Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Forest Therapy on Psychotic Patients: Focusing on Changes in Inflammatory Pathways and The Psychotic Condition of Patients

NCT07436481 is registered in ClinicalTrials.gov with Natalia Dewi Wardani, MD as lead sponsor.

NCT NCT07436481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07436481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Forest Therapy on Psychotic Patients: Focusing on Changes in Inflammatory Pathways and The Psychotic Condition of Patients
Lead sponsor
Natalia Dewi Wardani, MD
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2025
Completion date
December 31, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychotic disorder